|
ADPKD |
Autosomal Dominant Polycystic Kidney Disease |
|
AGREEII |
Appraisal of Guidelines for Research and Evaluation II |
|
β-HCA |
β-catenin Activated Hepatocellular Adenoma |
|
CRP |
C-reactive Protein |
|
CT |
Computed Tomography |
|
CEUS |
Contrast-Enhanced Ultrasound |
|
FNA |
Fine Needle Aspiration |
|
FNH |
Focal Nodular Hyperplasia |
|
GDG |
Guidelines Development Group |
|
GRADE |
Grading of Recommendations, Assessment, Development and Evaluation |
|
HCA |
Hepatocellular Adenoma |
|
HCC |
Hepatocellular Carcinoma |
|
H_HCA |
Hepatocyte Nuclear Factor _1a Hepatocellular Adenoma |
|
HNF-1a |
Hepatocyte Nuclear Factor-1a |
|
I-HCA |
Inflammatory Hepatocellular Adenomas |
|
MRI |
Magnetic Resonance Imaging |
|
OCP |
Oral Contraceptive Pills |
|
PAIR PCLD |
Puncture, Aspiration, Injection of Scolicidal Agent, and Reaspiration Polycystic Liver Disease |